Introduced:
Apr 4, 2025
Policy Area:
Health
Congress.gov:
Bill Statistics
2
Actions
1
Cosponsors
0
Summaries
1
Subjects
1
Text Versions
Yes
Full Text
AI Summary
AI Summary
No AI Summary Available
Click the button above to generate an AI-powered summary of this bill using Claude.
The summary will analyze the bill's key provisions, impact, and implementation details.
Error generating summary
Latest Action
Apr 4, 2025
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Actions (2)
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Type: IntroReferral
| Source: Senate
Apr 4, 2025
Introduced in Senate
Type: IntroReferral
| Source: Library of Congress
| Code: 10000
Apr 4, 2025
Subjects (1)
Health
(Policy Area)
Cosponsors (1)
(D-DE)
Apr 4, 2025
Apr 4, 2025
Full Bill Text
Length: 1,888 characters
Version: Introduced in Senate
Version Date: Apr 4, 2025
Last Updated: Nov 18, 2025 6:22 AM
[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[S. 1305 Introduced in Senate
(IS) ]
<DOC>
119th CONGRESS
1st Session
S. 1305
To allow for greater collaboration between the Biomedical Advanced
Research and Development Authority and the network of Manufacturing USA
institutes.
_______________________________________________________________________
IN THE SENATE OF THE UNITED STATES
April 4, 2025
Mr. Tillis (for himself and Mr. Coons) introduced the following bill;
which was read twice and referred to the Committee on Health,
Education, Labor, and Pensions
_______________________________________________________________________
A BILL
To allow for greater collaboration between the Biomedical Advanced
Research and Development Authority and the network of Manufacturing USA
institutes.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
[From the U.S. Government Publishing Office]
[S. 1305 Introduced in Senate
(IS) ]
<DOC>
119th CONGRESS
1st Session
S. 1305
To allow for greater collaboration between the Biomedical Advanced
Research and Development Authority and the network of Manufacturing USA
institutes.
_______________________________________________________________________
IN THE SENATE OF THE UNITED STATES
April 4, 2025
Mr. Tillis (for himself and Mr. Coons) introduced the following bill;
which was read twice and referred to the Committee on Health,
Education, Labor, and Pensions
_______________________________________________________________________
A BILL
To allow for greater collaboration between the Biomedical Advanced
Research and Development Authority and the network of Manufacturing USA
institutes.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1.
This Act may be cited as the ``Agility in Manufacturing
Preparedness Act of 2025''.
SEC. 2.
Section 319L
(c) (4)
(F) of the Public Health Service Act (42 U.
(c) (4)
(F) of the Public Health Service Act (42 U.S.C.
247d-7e
(c) (4)
(F) ) is amended--
(1) in the second sentence, in the matter preceding clause
(i) , by inserting ``, manufacturing technologies, platforms,''
after ``countermeasures''; and
(2) by inserting after the first sentence the following:
``Such strategic coordination may include collaborating with
the network of Manufacturing USA institutes established under
(F) of the Public Health Service Act (42 U.S.C.
247d-7e
(c) (4)
(F) ) is amended--
(1) in the second sentence, in the matter preceding clause
(i) , by inserting ``, manufacturing technologies, platforms,''
after ``countermeasures''; and
(2) by inserting after the first sentence the following:
``Such strategic coordination may include collaborating with
the network of Manufacturing USA institutes established under
section 34 of the National Institute of Standards and
Technology Act in biomanufacturing missions to develop,
demonstrate, and deploy technologies and response capabilities
to improve public health and medical preparedness.
Technology Act in biomanufacturing missions to develop,
demonstrate, and deploy technologies and response capabilities
to improve public health and medical preparedness.''.
<all>
demonstrate, and deploy technologies and response capabilities
to improve public health and medical preparedness.''.
<all>